Coronary artery stents: Review and patient-management recommendations

Journal of the American Dental Association

Volumn 131, Issue 6, 2000, Pages 797-801

  Roberts, Howard W ^a   Redding, Spencer W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; DENTAL CARE; DRUG INTERACTION; HUMAN; INSTRUMENTATION; MEDICAL SOCIETY; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES; UTILIZATION REVIEW;

AMERICAN HOSPITAL ASSOCIATION; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANTS; DENTAL CARE FOR CHRONICALLY ILL; DRUG INTERACTIONS; HUMANS; PLATELET AGGREGATION INHIBITORS; STENTS; UNITED STATES;

EID: 0034198466     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2000.0279     Document Type: Article

References (38)

1. American Heart Association. Cardiovascular Disease Statistics. Available at: "http://www.amhrt.org/ Heart_and_Stroke_A_Z_Guide/cvds.html". Accessed March 3, 1999.
2. Pepine CJ, Holmes DR Jr. Coronary artery stents. American College of Cardiology. J Am Cardiol 1996;28(3):782-94.
3. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1:263.
4. Goy JJ, Eeckhout E. Intracoronary stenting. Lancet 1998;351:1943-9.
5. Dotter CT. Transluminally-placed coil-spring endarterial tube grafts: long-term patency in canine popliteal artery. Invest Radiol 1969;4(5):329-32.
6. Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon expandable intracoronary stents in the adult dog. Circulation 1987;76:450-7.
7. Roubin GS, Robinson KA, King SB, et al. Early and late results of intracoronary artery stenting after coronary angioplasty in dogs. Circulation 1987;76:891-7.
8. Dotter CT, Buschmann RW, McKinney MK, Rosch J. Transluminal expanding nitinol coil stent grafting: preliminary report. Radiology 1983;147(1):259-60
9. Cragg A, Lund G, Rysavy J, Castaneda F, Castaneda-Zuniga W, Amplatz K. Nonsurgical placement of arterial endoprostheses: a new technique using nitinol wire. Radiology 1983;147(1):261-3.
10. Wright KC, Wallace S, Charnsangavej C, Carrasco CH, Gianturco C. Percutaneous endovascular stents: an experimental evaluation. Radiology 1985;156(1):69-72.
11. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;326:701-6.
12. Eeckhout E, Kappenberger L, Goy JL. Stents for intracoronary placement: current status and future directions. J Am Coll Cardiol 1996;27(4):757-65.
13. Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28(6): 1444-51.
14. Balcon R, Beyar R, Chierchia S. Recommendations on stent manufacture, implantation and utilization: study group of the working group on coronary circulation. Eur Heart J 1997;18:1536-47.
15. Holmes DR, Garratt KN, Popma J. Stent complications. J Invasive Cardiol 1998;10:385-395.
16. Serruys PW, Kutryk MJB. Handbook of coronary stents. 2nd ed. St Louis: Mosby 1998.
17. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II pilot study. Circulation 1996;93(3):412-22.
18. Oesterle SN, Whitbourn R, Fitzgerald PJ, et al. The stent decade: 1987-1997 - Stanford stent summit faculty. Am Heart J 1998;136:578-99.
19. Serrays PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent study group. N Engl J Med 1994;331(8):489-95.
20. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
21. Barragan P, Sainsous J, Silvestri M, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994;32:133-8.
22. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
23. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
24. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503.
25. Debbas NMG, Sigwart U, Eeckhout E, et al. Follow-up 8-10 years after stenting. In: Sigwart U, ed. Endoluminal stenting. London: Saunders; 1996:415.
26. Schuhlen H, Hausleiter J, Walter H, Wehinger A, Elezi S, Schomig A. Risk for major cardiac events with the first 30 days after coronary stent placement: analysis of 2216 procedures in 1621 patients (abstract 3659). Circulation 1997;96(8S):654.
27. Sutton JM, Ellis SG, Roubin GS, et al. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent placement - the Gianturco-Roubin intracoronary stent investigator group. Circulation 1994;89(3):1126-37.
28. Almagor Y, Feld S, Kiemeneij F, et al. First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation - the FINESS trial investigation. J Am Coll Cardiol 1997;30(4):847-54.
29. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97(25):2502-5.
30. Morice MC, Zemour G, Benveniste E, et al. Intracoronary stenting without Coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn 1995;35(1):1-7.
31. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93(2):215-22.
32. Elsner M, Peifer A, Drexler M, Wenzel C, Hebbeker C, Kasper W. Clinical outcome at six months of coronary stenting followed by ticlopidine monotherapy. Am J Cardiol 1998;81(2):147-51.
33. Mosby's genRx: The complete reference for generic and brand drugs. 9th ed. St. Louis: Mosby; 1999: II-2140-43.
34. Molony BA. An analysis of the side effects of ticlopidine. In: Hass WK, Easton JD, eds. Ticlopidine, platelets, and vascular disease. New York: Springer; 1993.
35. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;227:1794-801.
36. Pallasch TJ, Gage TW, Taubert KA. The 1997 prevention of bacterial endocarditis recommendations by the American Heart Association: questions and answers. J Calif Dent Assoc 1999;27(5):393-9.
37. Carter AJ, Scott D, Laird JR, et al. Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn 1998;44(2):193-201.
38. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99(1):44-52.